Paper19476376
Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer.
Parker WB. Chem Rev, 2009. Cited by 341 papers, by iCite.
Cite this record
ConductScience Library. Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. Papers, record 19476376. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19476376
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimetabolites, Antineoplastic | Major topic |
| Neoplasms | Major topic |
| Purines | Major topic |
| Pyrimidines | Major topic |
| Drug Design | |
| Genetic Therapy | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA124952 | NCI NIH HHS | United States | R01CA124952 | PubMed and NIH |
Source NIH RePORTER
References96
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1718594 | Action of 2',2'-difluorodeoxycytidine on DNA synthesis. | Cancer Res | 1991 | https://conductscience.org/library/papers/1718594 | PubMed |
| 2 | 12084452 | Development of transition state analogues of purine nucleoside phosphorylase as anti-T-cell agents. | Biochim Biophys Acta | 2002 | https://conductscience.org/library/papers/12084452 | PubMed |
| 3 | 1895307 | Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside. | J Med Chem | 1991 | https://conductscience.org/library/papers/1895307 | PubMed |
| 4 | 7533664 | Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cells. | Cancer Res | 1995 | https://conductscience.org/library/papers/7533664 | PubMed |
| 5 | 145246 | Thymidylate synthetase - a target enzyme in cancer chemotherapy. | Biochim Biophys Acta | 1977 | https://conductscience.org/library/papers/145246 | PubMed |
| 6 | 12811514 | The role of DNA synthesis inhibition in the cytotoxicity of 2',2'-difluoro-2'-deoxycytidine. | Cancer Chemother Pharmacol | 2003 | https://conductscience.org/library/papers/12811514 | PubMed |
| 7 | 2424284 | Azapyrimidine nucleosides: metabolism and inhibitory mechanisms. | Adv Enzyme Regul | 1985 | https://conductscience.org/library/papers/2424284 | PubMed |
| 8 | 18035189 | Nelarabine: a novel purine antimetabolite antineoplastic agent. | Clin Ther | 2007 | https://conductscience.org/library/papers/18035189 | PubMed |
| 9 | 15592840 | Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors. | Cancer Chemother Pharmacol | 2005 | https://conductscience.org/library/papers/15592840 | PubMed |
| 10 | 2444869 | Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template. | Mol Pharmacol | 1987 | https://conductscience.org/library/papers/2444869 | PubMed |
| 11 | 9634004 | Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells. | Biochem Pharmacol | 1998 | https://conductscience.org/library/papers/9634004 | PubMed |
| 12 | 14040670 | Some comparative studies of calf and chicken adenosine deaminase. | Arch Biochem Biophys | 1963 | https://conductscience.org/library/papers/14040670 | PubMed |
| 13 | 11686015 | Purine and pyrimidine nucleoside analogs. | Cancer Chemother Biol Response Modif | 2001 | https://conductscience.org/library/papers/11686015 | PubMed |
| 14 | 3050447 | Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase. | Mol Pharmacol | 1988 | https://conductscience.org/library/papers/3050447 | PubMed |
| 15 | 15374975 | Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene. | Cancer Res | 2004 | https://conductscience.org/library/papers/15374975 | PubMed |
| 16 | 16508625 | Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer. | Cancer Control | 2006 | https://conductscience.org/library/papers/16508625 | PubMed |
| 17 | 6600944 | Selective toxicity of deoxyguanosine and arabinosyl guanine for T-leukemic cells. | Blood | 1983 | https://conductscience.org/library/papers/6600944 | PubMed |
| 18 | 3971358 | Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts. | Cancer Res | 1985 | https://conductscience.org/library/papers/3971358 | PubMed |
| 19 | 9338077 | Ara-C: cellular and molecular pharmacology. | Adv Cancer Res | 1998 | https://conductscience.org/library/papers/9338077 | PubMed |
| 20 | 12203101 | Mechanisms of the apoptotic activity of Cl-F-araA in a human T-ALL cell line, CCRF-CEM. | Cancer Chemother Pharmacol | 2002 | https://conductscience.org/library/papers/12203101 | PubMed |
Cited by161
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 341 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42830607 | Triazole-Linked Pyrimidine Nucleoside Dimers: Design, Synthesis, and Applications in Medicinal and Nucleic Acid Chemistry. Part IV. | Chem Biol Drug Des | 2026 | https://conductscience.org/library/papers/42830607 | PubMed |
| 42457960 | Metabolite glues as a means of purine sensing and chemotherapeutic response. | Nature | 2026 | https://conductscience.org/library/papers/42457960 | PubMed |
| 42334544 | Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42334544 | PubMed |
| 42187140 | Anomer-Selective Vorbrüggen Reaction for the Catalytic Synthesis of C2-Deoxynucleoside Analogues. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/42187140 | PubMed |
| 42185727 | Engineering of a Nucleoside 2'-Deoxyribosyltransferase for Efficient Catalysis of 5-Halogenated-2'-Deoxypyrimidine Nucleosides via Active-Site Channel Expansion. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/42185727 | PubMed |
| 41908450 | Investigating the Therapeutic Activity of C4N as a Targeted Drug Delivery System for Acetaminophen and Thioguanine through DFT Simulations. | ACS Omega | 2026 | https://conductscience.org/library/papers/41908450 | PubMed |
| 41828812 | In Vitro Safety Profiling and Leukoderma-Relevant Hazard Assessment of Raspberry Ketone Versus Polygonum cillinerve Total Anthraquinones in a Keratinocyte-Melanocyte Co-Culture Model. | Molecules | 2026 | https://conductscience.org/library/papers/41828812 | PubMed |
| 41822749 | Biological evaluation of novel 6,9-disubstituted purine analogues in high-grade serous ovarian cancer cell lines. | Turk J Biol | 2026 | https://conductscience.org/library/papers/41822749 | PubMed |
| 41688441 | Structural and molecular basis for allosteric regulation and catalytic coupling of human phosphoribosylformylglycinamidine synthase. | Nat Commun | 2026 | https://conductscience.org/library/papers/41688441 | PubMed |
| 41631161 | Pyrimidine-based compounds as promising anticancer agents targeting tumor cell senescence. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/41631161 | PubMed |
| 41208707 | Salvage Treatment Options for Posttransplant Relapse in Children with Early/Very Early Relapse of Acute Lymphoblastic Leukemia: A Single-Center Experience | Turk J Haematol | 2026 | https://conductscience.org/library/papers/41208707 | PubMed |
| 41198929 | Effects of nucleic acid metabolism on prognosis and immune invasion of triple-negative breast cancer. | Genes Immun | 2026 | https://conductscience.org/library/papers/41198929 | PubMed |
| 41124688 | Development of a Real-Time Fluorescence-Based Deamination Assay and Identification of Inhibitors of Human Cytidine Deaminase. | ACS Chem Biol | 2025 | https://conductscience.org/library/papers/41124688 | PubMed |
| 41122147 | 5-Amino- and 6-amino-uracils in the synthesis of various heterocycles as therapeutic agents: a review. | RSC Adv | 2025 | https://conductscience.org/library/papers/41122147 | PubMed |
| 41034321 | Purine-based chemical probe with HOMO switching for intracellular detection of mercury ions. | Sci Rep | 2025 | https://conductscience.org/library/papers/41034321 | PubMed |
| 40956032 | Metabolic Reprogramming of Cancer Cells and Therapeutics Targeting Cancer Metabolism. | Cancer Med | 2025 | https://conductscience.org/library/papers/40956032 | PubMed |
| 40940612 | Integrating Metabolic Modulation and Nanomedicine for Cancer Immunotherapy. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40940612 | PubMed |
| 40702234 | Novel purine-linked 1,2,3-triazole derivatives as effective anticancer agents: design, synthesis, docking, DFT, and ADME-T investigations. | Sci Rep | 2025 | https://conductscience.org/library/papers/40702234 | PubMed |
| 40649226 | Hybrid Molecules with Purine and Pyrimidine Derivatives for Antitumor Therapy: News, Perspectives, and Future Directions. | Molecules | 2025 | https://conductscience.org/library/papers/40649226 | PubMed |
| 40567473 | From molecule to medicine: introducing emerging strategies to synthesize potent anticancer purine scaffolds. | RSC Adv | 2025 | https://conductscience.org/library/papers/40567473 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19476376
GET https://conductscience.org/api/papers/v1/19476376/references?page=2